🇺🇸 FDA
Patent

US 9370525

Modified release preparations containing oxcarbazepine and derivatives thereof

granted A61KA61K2800/56A61K31/55

Quick answer

US patent 9370525 (Modified release preparations containing oxcarbazepine and derivatives thereof) held by Supernus Pharmaceuticals, Inc. expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Supernus Pharmaceuticals, Inc.
Grant date
Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2800/56, A61K31/55, A61K9/0073, A61K9/2013